Form D — ImmuneBridge Inc.
0001960306-25-000003 · filed 2025-04-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $7,132,000
- Total sold
- $5,632,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ImmuneBridge Inc.
- CIK
- 1960306
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 2122 BRYANT ST
SAN FRANCISCO, CA 94110 - Phone
- 415-527-5634
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stuart Alexander Jacobson · Executive OfficerSan Francisco, CA Find on LinkedIn ↗
-
Dylan Morris · DirectorNew York, NY Find on LinkedIn ↗
-
Nadiya Ishnazarova · DirectorAmsterdam, P7 Find on LinkedIn ↗
-
Omri Amirav-Drory · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Thomas Farrell · DirectorSan Francisco, CA Find on LinkedIn ↗
-
Alicia Jackson · DirectorSan Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.